Avadel Pharmaceuticals Plc Stock Today
| AVDL Stock | USD 18.09 0.79 4.57% |
Performance9 of 100
| Odds Of DistressLess than 8
|
Avadel Pharmaceuticals is selling for 18.09 as of the 23rd of April 2024. This is a 4.57% increase since the beginning of the trading day. The stock's lowest day price was 17.26. Avadel Pharmaceuticals has only a 8 % chance of going through financial distress over the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Avadel Pharmaceuticals PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of July 2023 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 7th of June 1996 | Category Healthcare | Classification Health Care |
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Avadel Pharmaceuticals is traded on NASDAQ Exchange in the United States. The company has 90.58 M outstanding shares of which 10.39 M shares are presently shorted by private and institutional investors with about 6.47 trading days to cover. More on Avadel Pharmaceuticals PLC
Moving together with Avadel Stock
| 0.61 | A | Agilent Technologies Earnings Call This Week | PairCorr |
| 0.67 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
| 0.8 | ERNA | Eterna Therapeutics | PairCorr |
Moving against Avadel Stock
| 0.83 | DNA | Ginkgo Bioworks Holdings Financial Report 8th of May 2024 | PairCorr |
| 0.61 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.5 | EGRX | Eagle Pharmaceuticals | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
Avadel Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Avadel Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Avadel Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Director | Michael Anderson | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Avadel Pharmaceuticals report their recommendations after researching Avadel Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Avadel Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Avadel Pharmaceuticals. The Avadel consensus assessment is calculated by taking the average forecast from all of the analysts covering Avadel Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Avadel Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Avadel Pharmaceuticals PLC is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Avadel Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Avadel Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Avadel Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Avadel Pharmaceuticals' financial leverage. It provides some insight into what part of Avadel Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Avadel Pharmaceuticals PLC (AVDL) is traded on NASDAQ Exchange in USA. It is located in 10 Earlsfort Terrace, Dublin, Ireland, 2 and employs 154 people. Avadel Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avadel Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Avadel Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Avadel Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 90.58 M outstanding shares of which 10.39 M shares are presently shorted by private and institutional investors with about 6.47 trading days to cover.
Avadel Pharmaceuticals PLC currently holds about 104.12 M in cash with (132.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.74.
Check Avadel Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationAvadel Pharmaceuticals holds a total of 90.58 Million outstanding shares. Over half of Avadel Pharmaceuticals' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Avadel Pharmaceuticals. Please watch out for any change in the institutional holdings of Avadel Pharmaceuticals as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Avadel Ownership Details
Avadel Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Avadel Pharmaceuticals jumping above the current price in 90 days from now is under 4%. The Avadel Pharmaceuticals PLC probability density function shows the probability of Avadel Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.3588. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Avadel Pharmaceuticals will likely underperform. Additionally, avadel Pharmaceuticals PLC has an alpha of 0.1548, implying that it can generate a 0.15 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Avadel Pharmaceuticals to move above the current price in 90 days from now is under 4 (This Avadel Pharmaceuticals PLC probability density function shows the probability of Avadel Stock to fall within a particular range of prices over 90 days) .
Avadel Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Avadel Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Avadel Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Avadel Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Goldman Sachs Group Inc | 2023-12-31 | 974.5 K | |
| Samsara Biocapital, Llc | 2023-12-31 | 967.5 K | |
| Tri Locum Partners Lp | 2023-12-31 | 839.9 K | |
| Balyasny Asset Management Llc | 2023-12-31 | 781.5 K | |
| Mpm Oncology Impact Management Lp | 2023-12-31 | 665 K | |
| Kennedy Capital Management Inc | 2023-12-31 | 645.9 K | |
| Renaissance Technologies Corp | 2023-12-31 | 625.1 K | |
| Knoll Capital Management Lp | 2023-12-31 | 600 K | |
| Modera Wealth Management, Llc | 2023-12-31 | 598.4 K | |
| Hhg Plc | 2023-12-31 | 11.1 M | |
| Rtw Investments, Llc | 2023-12-31 | 6.9 M |
Avadel Pharmaceuticals Historical Income Statement
Avadel Pharmaceuticals PLC Income Statement is one of the three primary financial statements used for reporting Avadel's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Avadel Pharmaceuticals revenue and expense. Avadel Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Avadel Pharmaceuticals' Total Operating Expenses is quite stable compared to the past year. Non Operating Income Net Other is expected to rise to about 2.4 M this year, although the value of Operating Income is projected to rise to (131 M). View More FundamentalsAvadel Stock Against Markets
Picking the right benchmark for Avadel Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Avadel Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Avadel Pharmaceuticals is critical whether you are bullish or bearish towards Avadel Pharmaceuticals PLC at a given time. Please also check how Avadel Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Avadel Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Avadel Pharmaceuticals Corporate Directors
Avadel Pharmaceuticals corporate directors refer to members of an Avadel Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Avadel Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Avadel Pharmaceuticals' board members must vote for the resolution. The Avadel Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Kevin Kotler | Director | Profile | |
| Benoit Assche | Independent Director | Profile | |
| Christophe Navarre | Independent Director | Profile | |
| Francis Fildes | Independent Director | Profile |
How to buy Avadel Stock?
Before investing in Avadel Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Avadel Pharmaceuticals. To buy Avadel Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Avadel Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Avadel Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Avadel Pharmaceuticals PLC stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Avadel Pharmaceuticals PLC stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Avadel Pharmaceuticals PLC, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Avadel Stock please use our How to Invest in Avadel Pharmaceuticals guide.
Already Invested in Avadel Pharmaceuticals PLC?
The danger of trading Avadel Pharmaceuticals PLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Avadel Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Avadel Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Avadel Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Avadel Pharmaceuticals is a strong investment it is important to analyze Avadel Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avadel Pharmaceuticals' future performance. For an informed investment choice regarding Avadel Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Avadel Pharmaceuticals information on this page should be used as a complementary analysis to other Avadel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Avadel Stock analysis
When running Avadel Pharmaceuticals' price analysis, check to measure Avadel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avadel Pharmaceuticals is operating at the current time. Most of Avadel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Avadel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avadel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Avadel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Avadel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.00) | Revenue Per Share 0.349 | Quarterly Revenue Growth (1.00) | Return On Assets (0.58) | Return On Equity (4.81) |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.